Relapsed Adult Acute Myeloid Leukemia Recruiting Phase 1 / 2 Trials for Adenosine (DB00640)

IndicationStatusPhase
DBCOND0075222 (Relapsed Adult Acute Myeloid Leukemia)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT025095468-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTreatment